EXAS today

$104.91+$0.99 (+0.95%)close Mar 20, 2026

Trend

—

Key levels

Resistance$107.00

Resistance$106.58

Support$104.50

Support$104.00

Latest news & SEC filings

No headlines in the last 90 days.

· Healthcare

EXACT SCIENCES CORP (EXAS)

$104.91+0.99 (+0.95%)
WATCHLISTGrade: BRisk: LOW
1D5D1M1Y5YMaxSign up for all timeframes
103.5103.9104.2104.6104.91Feb 17Feb 25Mar 5Mar 13
High104.98
Low104.90
Open104.93
Volume19.84M
Avg Vol2.66M
VWAP104.94
30d High104.91
30d Low103.18
30d Chg+1.68%
See full chart with real-time data

What Is the Price Target for EXAS?

SEPT Low Target

$0.00

SEPT Mid Target

$0.00

SEPT High Target

$0.00

Analyst Consensus

$0.00

Current: $104.91Upside: +0.0%Confidence: 20%Method: No Coverage

Is EXAS a Buy or Sell Right Now?

60
Investability Score
WATCHLIST12-18 months

Thesis

  • •Revenue growing 17.7% YoY with ACCELERATING trend — accelerating momentum.

AI-Powered Trading Signals

Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy for EXAS.

Start Free Trial →

Is EXAS Overvalued or Undervalued?

Valuation Verdict

OVERVALUED

Methods Used

P/E Forward, P/B, PEG

Fair Value

$18.55

35

Moat Score

NONE

5/9

Piotroski Score

3.0

Altman Z-Score

What Is Smart Money Doing with EXAS?

Insider Signal

NEUTRAL

0 buys / 0 sells (90d)

Congress Signal

NEUTRAL

0 buys / 0 sells (90d)

Institutional

DISTRIBUTING

Short Squeeze Risk

HIGH

Signal: HIGH_SHORT_INTEREST

Track Smart Money Across 4,000+ Stocks

Insider trades, congress trades, institutional flows, and short interest — updated daily with real-time alerts.

See All Smart Money Signals →

EXAS Growth Story

Revenue YoY

17.7%

3yr Revenue CAGR

N/A%

EPS Growth YoY

80.32%

FCF Growth YoY

378.6%

Revenue Trend

ACCELERATING

Full AI Research Report

SEPT's Trading AI has generated a free, downloadable PDF research report for EXACT SCIENCES CORP (EXAS) covering valuation analysis, financial health assessment, growth projections, smart money tracking, earnings and key price levels. For research only, not investment advice.

Report includes: PDF download, detailed valuation models (DCF, P/E, EV/EBITDA), institutional flow analysis, congress and insider trade tracking, FinBERT news sentiment (1 articles analyzed), and SEC filing intelligence...

Sign Up Free — Download AI Report PDF →

AI-Powered Trading Signals.

Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy. SEPT tells you when to buy, when to sell, and grades every stock so you never trade blind.

Try SEPT Free for 7 Days →

Compare SEPT with other platforms

SEPT vs TradingViewSEPT vs BloombergSEPT vs Unusual WhalesSEPT vs SpotGammaSEPT vs TrendSpiderAI Trading Platforms Compared
What is dark pool trading?How to read options flowGEX explainedSmart money trackingAI stock analysisEarn money on SEPT

About SEPT Investing

SEPT Investing tracks 13,000+ stocks with live charts, trend and key-level tracking, dark pool and options flow, insider and congress trades, SEC filings and news alerts.

Disclaimer: This page is for informational purposes only. It does not constitute financial advice. Past performance does not guarantee future results. Always do your own research before making investment decisions.

EXAS — frequently asked questions

What is EXAS stock price today?

EXACT SCIENCES CORP (EXAS) is at $104.91, up 0.95% (+$0.99) at the Mar 20, 2026 close.

Did EXAS beat earnings?

EXAS last reported on Feb 13, 2026: EPS -$0.45 vs -$0.11 expected — a miss of 317.1%.

Does EXAS pay a dividend?

EXAS does not currently pay a dividend.

What are EXAS support and resistance levels?

Support: $104.50, $104.00, $103.22. Resistance: $106.58, $107.00, $108.04.

What are insiders doing with EXAS?

Insider activity: NEUTRAL, 0 buys and 0 sells in the last 90 days.